Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Dendrimer therapy effective against excessive post-eye surgery scarring

May 11, 2004

Novel PAF antagonist protects eyes against alkali and light-induced damage

May 11, 2004

Intravitreal pegaptanib reported safe and effective in ocular neovascularization disorders

May 10, 2004

Dose-dependent activity of EGT-001 in ocular angiogenesis model

May 7, 2004

Novel somatostatin analogue may be effective in diabetic retinopathy

May 7, 2004

Angiocol inhibits retinal angiogenesis in vitro

May 7, 2004

Prostaglandin derivative DE-085 increases retinal blood flow

May 6, 2004

St. John's wort and hypericin may prevent diabetic and premature retinopathy

May 6, 2004

Specific cannabinoid receptor agonist may prevent tissue damage in retina

May 5, 2004

Tyrosine kinase inhibitor blocks choroidal neovascularization

May 4, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...